ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 183 filers reported holding ENANTA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 4.93 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $765,659 | -64.4% | 68,546 | -31.8% | 0.01% | -57.1% |
Q2 2023 | $2,150,443 | +46.6% | 100,488 | +177.0% | 0.01% | +55.6% |
Q1 2023 | $1,466,799 | -9.5% | 36,271 | +4.2% | 0.01% | 0.0% |
Q4 2022 | $1,620,012 | -22.6% | 34,824 | -13.6% | 0.01% | -25.0% |
Q3 2022 | $2,092,000 | +18.3% | 40,323 | +7.7% | 0.01% | +9.1% |
Q2 2022 | $1,769,000 | +491.6% | 37,423 | +791.9% | 0.01% | +266.7% |
Q1 2022 | $299,000 | -91.5% | 4,196 | -91.0% | 0.00% | -90.9% |
Q4 2021 | $3,504,000 | +440.7% | 46,851 | +310.5% | 0.03% | +312.5% |
Q3 2021 | $648,000 | +222.4% | 11,413 | +180.3% | 0.01% | +166.7% |
Q1 2021 | $201,000 | -69.3% | 4,072 | -71.6% | 0.00% | -70.0% |
Q3 2020 | $655,000 | +31.5% | 14,316 | +44.3% | 0.01% | +11.1% |
Q2 2020 | $498,000 | +69.4% | 9,919 | +73.8% | 0.01% | +12.5% |
Q1 2020 | $294,000 | -40.7% | 5,708 | -28.8% | 0.01% | -11.1% |
Q4 2019 | $496,000 | +47.6% | 8,021 | +43.5% | 0.01% | +28.6% |
Q3 2019 | $336,000 | -18.8% | 5,588 | +14.0% | 0.01% | -12.5% |
Q2 2019 | $414,000 | +16.3% | 4,903 | +31.5% | 0.01% | -33.3% |
Q1 2019 | $356,000 | +51.5% | 3,728 | +12.3% | 0.01% | +9.1% |
Q4 2018 | $235,000 | -56.5% | 3,321 | -28.7% | 0.01% | -59.3% |
Q2 2018 | $540,000 | +14.2% | 4,661 | -20.3% | 0.03% | -3.6% |
Q1 2018 | $473,000 | +75.2% | 5,850 | +27.0% | 0.03% | +100.0% |
Q4 2017 | $270,000 | +2900.0% | 4,607 | +1435.7% | 0.01% | +1300.0% |
Q1 2017 | $9,000 | – | 300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Krensavage Asset Management, LLC | 936,777 | $53,218,000 | 16.69% |
Fairmount Funds Management LLC | 316,952 | $18,006,000 | 6.55% |
ARMISTICE CAPITAL, LLC | 1,836,000 | $104,303,000 | 1.77% |
Soleus Capital Management, L.P. | 182,400 | $10,362,000 | 1.62% |
Portland Global Advisors LLC | 62,635 | $3,558,000 | 0.66% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 40,000 | $2,263,000 | 0.55% |
FARALLON CAPITAL MANAGEMENT LLC | 1,995,000 | $113,336,000 | 0.53% |
Yorktown Management & Research Co Inc | 10,400 | $591,000 | 0.44% |
Hennion & Walsh Asset Management, Inc. | 120,240 | $6,831,000 | 0.36% |
Virtus ETF Advisers LLC | 9,599 | $545,000 | 0.24% |